154 related articles for article (PubMed ID: 2339144)
1. Temporal differences in behavioral effect of fenfluramine and norfenfluramine.
Schechter MD
Pharmacol Biochem Behav; 1990 Mar; 35(3):527-31. PubMed ID: 2339144
[TBL] [Abstract][Full Text] [Related]
2. Norfenfluramine, the fenfluramine metabolite, provides stimulus control: evidence for serotonergic mediation.
Boja JW; Schechter MD
Pharmacol Biochem Behav; 1988 Oct; 31(2):305-11. PubMed ID: 3244707
[TBL] [Abstract][Full Text] [Related]
3. Comparison of anorectic drugs in rats trained to discriminate between satiation and deprivation.
Schechter MD
Life Sci; 1990; 47(1):17-24. PubMed ID: 2388514
[TBL] [Abstract][Full Text] [Related]
4. Effect of fenfluramine and norfenfluramine stereoisomers on stimulant effects of d-amphetamine and apomorphine in the rat.
Bendotti C; Borsini F; Zanini MG; Samanin R; Garattini S
Pharmacol Res Commun; 1980 Jun; 12(6):567-74. PubMed ID: 7190710
[No Abstract] [Full Text] [Related]
5. Effect of (+)- or (-)-enantiomers of fenfluramine or norfenfluramine on nutrient selection by rats.
Hirsch JA; Goldberg S; Wurtman RJ
J Pharm Pharmacol; 1982 Jan; 34(1):18-21. PubMed ID: 6121026
[TBL] [Abstract][Full Text] [Related]
6. Comparative studies on the anorectic activity of d-fenfluramine in mice, rats, and guinea pigs.
Mennini T; Bizzi A; Caccia S; Codegoni A; Fracasso C; Frittoli E; Guiso G; Padura IM; Taddei C; Uslenghi A
Naunyn Schmiedebergs Arch Pharmacol; 1991 May; 343(5):483-90. PubMed ID: 1881458
[TBL] [Abstract][Full Text] [Related]
7. Discriminative stimulus properties of fenfluramine: evidence for serotonergic involvement.
McElroy JF; Feldman RS
Psychopharmacology (Berl); 1984; 83(2):172-8. PubMed ID: 6431469
[TBL] [Abstract][Full Text] [Related]
8. Suppression of behavioral activity by norfenfluramine and related drugs in rats is not mediated by serotonin release.
Callaway CW; Wing LL; Nichols DE; Geyer MA
Psychopharmacology (Berl); 1993; 111(2):169-78. PubMed ID: 7870948
[TBL] [Abstract][Full Text] [Related]
9. The role of d-norfenfluramine in the indole-depleting effect of d-fenfluramine in the rat.
Caccia S; Anelli M; Ferrarese A; Fracasso C; Garattini S
Eur J Pharmacol; 1993 Mar; 233(1):71-7. PubMed ID: 7682511
[TBL] [Abstract][Full Text] [Related]
10. Discriminative stimulus properties of fenfluramine in an operant task: an analysis of its cue function.
Goudie AJ
Psychopharmacology (Berl); 1977 Jun; 53(1):97-102. PubMed ID: 407619
[No Abstract] [Full Text] [Related]
11. Functional consequences of fenfluramine neurotoxicity.
Schechter MD
Pharmacol Biochem Behav; 1990 Dec; 37(4):623-6. PubMed ID: 2093166
[TBL] [Abstract][Full Text] [Related]
12. Fenfluramine discrimination in obese and lean Zucker rats: serotonergic mediation of effect.
Schechter MD
Eur J Pharmacol; 1986 Jun; 125(1):135-41. PubMed ID: 3732388
[TBL] [Abstract][Full Text] [Related]
13. Comparative serotonin neurotoxicity of the stereoisomers of fenfluramine and norfenfluramine.
Johnson MP; Nichols DE
Pharmacol Biochem Behav; 1990 May; 36(1):105-9. PubMed ID: 2140899
[TBL] [Abstract][Full Text] [Related]
14. Differences between d-fenfluramine and d-norfenfluramine in serotonin presynaptic mechanisms.
Borroni E; Ceci A; Garattini S; Mennini T
J Neurochem; 1983 Mar; 40(3):891-3. PubMed ID: 6827286
[TBL] [Abstract][Full Text] [Related]
15. (+)-Fenfluramine and its major metabolite, (+)-norfenfluramine, are potent substrates for norepinephrine transporters.
Rothman RB; Clark RD; Partilla JS; Baumann MH
J Pharmacol Exp Ther; 2003 Jun; 305(3):1191-9. PubMed ID: 12649307
[TBL] [Abstract][Full Text] [Related]
16. On the in vivo and in vitro actions of fenfluramine and its derivatives on central monoamine neurons, especially 5-hydroxytryptamine neurons, and their relation to the anorectic activity of fenfluramine.
Fuxe K; Farnebo LO; Hamberger B; Ogren SO
Postgrad Med J; 1975; 51 Suppl 1():35-45. PubMed ID: 1219678
[No Abstract] [Full Text] [Related]
17. Stimulus generalization by fenfluramine in a quipazine-ketanserin drug discrimination is not dependent on indirect serotonin release.
Smith RL; Gresch PJ; Barrett RJ; Sanders-Bush E
Pharmacol Biochem Behav; 2002 May; 72(1-2):77-85. PubMed ID: 11900772
[TBL] [Abstract][Full Text] [Related]
18. Effects of intracerebroventricular administration of d-fenfluramine and d-norfenfluramine, as a single injection or 2-hr infusion, on serotonin in brain: relationship to concentrations of drugs in brain.
Invernizzi R; Fracasso C; Caccia S; Garattini S; Samanin R
Neuropharmacology; 1991 Feb; 30(2):119-23. PubMed ID: 2030819
[TBL] [Abstract][Full Text] [Related]
19. Is receptor activation involved in the mechanism by which (+)-fenfluramine and (+)-norfenfluramine deplete 5-hydroxytryptamine in the rat brain?
Invernizzi R; Kmieciak-Kolada K; Samanin R
Br J Pharmacol; 1982 Mar; 75(3):525-30. PubMed ID: 6175368
[TBL] [Abstract][Full Text] [Related]
20. Effect of dopamine agonists and fenfluramine on discriminative behavior in obese and lean Zucker rats.
Schechter MD; Finkelstein JA
Pharmacol Biochem Behav; 1985 Jul; 23(1):7-11. PubMed ID: 4034621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
